Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 9Carcinoma, Intraductal, Noninfiltrating 4Breast Carcinoma In Situ 4Liver Neoplasms 3Carcinoma, Hepatocellular 3Squamous Cell Carcinoma of Head and Neck 2Salivary Gland Neoplasms 2Prostatic Neoplasms 2Precancerous Conditions 2Pancreatic Neoplasms 2Lung Neoplasms 2Leukemia, Myeloid, Acute 2Leukemia 2Head and Neck Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Urinary Bladder Neoplasms 1Urethral Neoplasms 1Unspecified Childhood Solid Tumor, Protocol Specific 1Small Cell Lung Carcinoma 1Sarcoma 1Rectal Neoplasms 1Ovarian Neoplasms 1Neuroblastoma 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma 1Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Erythroblastic, Acute 1

Interventions

Sunitinib 17Sorafenib 16pazopanib 7cabozantinib 7Axitinib 7Blood Specimen Collection 6Bevacizumab 6avelumab 5Immunohistochemistry 5temsirolimus 4pembrolizumab 3Watchful Waiting 3Specimen Handling 3Immunotherapy 3Gene Expression Profiling 3Everolimus 3Urine Specimen Collection 2Nephrectomy 2Magnetic Resonance Spectroscopy 2Magnetic Resonance Imaging 2Flow Cytometry 2Data Collection 2Amplified Fragment Length Polymorphism Analysis 2trastuzumab deruxtecan 1lenvatinib 1fluoroazomycin arabinoside 1enfortumab vedotin 1darolutamide 1atezolizumab 1aldesleukin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Carcinoma, Renal Cell × Mass Spectrometry × Clear all
NCT00900276 2018-07-05

Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants

Wake Forest University Health Sciences

Completed
5 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Kidney Neoplasms, Urethral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡